Generated Narrative: ValueSet ch-vacd-ch-vaccination-plan-immunizations-vs Include these codes as defined in http://snomed.info/sct version Not Stated (use latest from terminology server) Code Display 42284007 Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure) 76668005 Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure) 127787002 Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure) 243789007 Administration of vaccine product containing only Hepatitis A virus antigen (procedure) 16584000 Administration of vaccine product containing only Hepatitis B virus antigen (procedure) 86198006 Administration of vaccine product containing only Influenza virus antigen (procedure) 314759000 Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure) 47435007 Administration of vaccine product containing only Measles morbillivirus antigen (procedure) 719596001 Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) 314417000 Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) 871874000 Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure) 50583002 Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure) 761841000 Administration of vaccine product containing only Human papillomavirus antigen (procedure) 39343008 Administration of vaccine product containing only Bordetella pertussis antigen (procedure) 1119368005 Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure) 1119366009 Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure) 1119367000 Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure) 72093006 Administration of vaccine product containing only Human poliovirus antigen (procedure) 34631000 Administration of vaccine product containing only Rabies lyssavirus antigen (procedure) 82314000 Administration of vaccine product containing only Rubella virus antigen (procedure) 127786006 Administration of vaccine product containing only Clostridium tetani antigen (procedure) 281658005 Administration of vaccine product containing only Tick-borne encephalitis virus antigen (procedure) 15483003 Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure) 737081007 Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure) 722215002 Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles (procedure) 67308009 Administration of vaccine product containing only Yellow fever virus antigen (procedure) 1157107003 Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure) 1119350007 Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure) 1209198003 Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure) 1162645008 Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)
CH VACD Swiss Vaccination Plan Immunizations
Immunization procedures for recommendations according to the vaccination plan.
Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure)
Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure)
Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure)
Administration of vaccine product containing only Hepatitis A virus antigen (procedure)
Administration of vaccine product containing only Hepatitis B virus antigen (procedure)
Administration of vaccine product containing only Influenza virus antigen (procedure)
Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure)
Administration of vaccine product containing only Measles morbillivirus antigen (procedure)
Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure)
Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure)
Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure)
Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure)
Administration of vaccine product containing only Human papillomavirus antigen (procedure)
Administration of vaccine product containing only Bordetella pertussis antigen (procedure)
Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure)
Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure)
Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure)
Administration of vaccine product containing only Human poliovirus antigen (procedure)
Administration of vaccine product containing only Rabies lyssavirus antigen (procedure)
Administration of vaccine product containing only Rubella virus antigen (procedure)
Administration of vaccine product containing only Clostridium tetani antigen (procedure)
Administration of vaccine product containing only Tick-borne encephalitis virus antigen (procedure)
Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure)
Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)
Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles (procedure)
Administration of vaccine product containing only Yellow fever virus antigen (procedure)
Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure)
Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure)
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)